Investors Notified of Class Action Lawsuits Against Biogen, Charge Enterprises, and Fastly
Jun 21, 2024
Biogen Stock Market Invest
FDA Accepts Eisai's LEQEMBI® Supplemental Biologics License Application for Alzheimer's
Jun 10, 2024
Bragar Eagel & Squire, P.C. Announces Class Actions on Behalf of Shareholders of Biogen, Charge, and Fastly
Jun 10, 2024
National Law Firm Alerts Investors of Class Action Lawsuits Against Biogen, Charge Enterprises, and Fastly
Jun 7, 2024
Biogen Joins Forces with Delta Flight Products to Enhance Accessible Air Travel
Jun 4, 2024
Biogen’s Pioneering Friedreich's Ataxia Treatment SKYCLARYS® Receives Validation from CHMP
Dec 16, 2023